Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13


Releasing the concept of HLA-allele specific peptide anchors in viral infections: A non-canonical naturally presented human cytomegalovirus-derived HLA-A*24:02 restricted peptide drives exquisite immunogenicity.

Pump WC, Schulz R, Huyton T, Kunze-Schumacher H, Martens J, Hò GT, Blasczyk R, Bade-Doeding C.

HLA. 2019 Jul;94(1):25-38. doi: 10.1111/tan.13537. Epub 2019 Apr 14.


miR-181a/b-1 controls thymic selection of Treg cells and tunes their suppressive capacity.

Łyszkiewicz M, Winter SJ, Witzlau K, Föhse L, Brownlie R, Puchałka J, Verheyden NA, Kunze-Schumacher H, Imelmann E, Blume J, Raha S, Sekiya T, Yoshimura A, Frueh JT, Ullrich E, Huehn J, Weiss S, Gutierrez MG, Prinz I, Zamoyska R, Ziętara N, Krueger A.

PLoS Biol. 2019 Mar 11;17(3):e2006716. doi: 10.1371/journal.pbio.2006716. eCollection 2019 Mar.


Germ Line Deletion Reveals a Nonessential Role of Atypical Mitogen-Activated Protein Kinase 6/Extracellular Signal-Regulated Kinase 3.

Ronkina N, Schuster-Gossler K, Hansmann F, Kunze-Schumacher H, Sandrock I, Yakovleva T, Lafera J, Baumgärtner W, Krueger A, Prinz I, Gossler A, Kotlyarov A, Gaestel M.

Mol Cell Biol. 2019 Mar 1;39(6). pii: e00516-18. doi: 10.1128/MCB.00516-18. Print 2019 Mar 15.


Interactions in the ESCRT-III network of the yeast Saccharomyces cerevisiae.

Brune T, Kunze-Schumacher H, Kölling R.

Curr Genet. 2019 Apr;65(2):607-619. doi: 10.1007/s00294-018-0915-8. Epub 2018 Dec 1.


miRNA miR-21 Is Largely Dispensable for Intrathymic T-Cell Development.

Kunze-Schumacher H, Winter SJ, Imelmann E, Krueger A.

Front Immunol. 2018 Nov 5;9:2497. doi: 10.3389/fimmu.2018.02497. eCollection 2018.


Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B∗15:02.

Simper GS, Hò GT, Celik AA, Huyton T, Kuhn J, Kunze-Schumacher H, Blasczyk R, Bade-Döding C.

J Immunol Res. 2018 Sep 13;2018:5086503. doi: 10.1155/2018/5086503. eCollection 2018.


MicroRNA miR-181a/b-1 controls MAIT cell development.

Winter SJ, Kunze-Schumacher H, Imelmann E, Grewers Z, Osthues T, Krueger A.

Immunol Cell Biol. 2019 Feb;97(2):190-202. doi: 10.1111/imcb.12211. Epub 2018 Nov 12.


miR-191 modulates B-cell development and targets transcription factors E2A, Foxp1, and Egr1.

Blume J, Ziętara N, Witzlau K, Liu Y, Sanchez OO, Puchałka J, Winter SJ, Kunze-Schumacher H, Saran N, Düber S, Roy B, Weiss S, Klein C, Wurst W, Łyszkiewicz M, Krueger A.

Eur J Immunol. 2019 Jan;49(1):121-132. doi: 10.1002/eji.201847660. Epub 2018 Oct 22.


The polymorphism at residue 156 determines the HLA-B*35 restricted peptide repertoire during HCMV infection.

Abels WC, Manandhar T, Kunze-Schumacher H, Blasczyk R, Bade-Döding C.

Immunogenetics. 2018 Nov;70(10):639-646. doi: 10.1007/s00251-018-1077-z. Epub 2018 Aug 21.


Understanding the obstacle of incompatibility at residue 156 within HLA-B*35 subtypes.

Manandhar T, Kunze-Schumacher H, Huyton T, Celik AA, Blasczyk R, Bade-Doeding C.

Immunogenetics. 2016 Apr;68(4):247-60. doi: 10.1007/s00251-015-0896-4. Epub 2016 Jan 12.


HLA-E: Presentation of a Broader Peptide Repertoire Impacts the Cellular Immune Response-Implications on HSCT Outcome.

Kraemer T, Celik AA, Huyton T, Kunze-Schumacher H, Blasczyk R, Bade-Döding C.

Stem Cells Int. 2015;2015:346714. doi: 10.1155/2015/346714. Epub 2015 Aug 12.


A Micropolymorphism Altering the Residue Triad 97/114/156 Determines the Relative Levels of Tapasin Independence and Distinct Peptide Profiles for HLA-A(*)24 Allotypes.

Badrinath S, Kunze-Schumacher H, Blasczyk R, Huyton T, Bade-Doeding C.

J Immunol Res. 2014;2014:298145. doi: 10.1155/2014/298145. Epub 2014 Dec 4.


Soluble HLA technology as a strategy to evaluate the impact of HLA mismatches.

Kunze-Schumacher H, Blasczyk R, Bade-Doeding C.

J Immunol Res. 2014;2014:246171. doi: 10.1155/2014/246171. Epub 2014 Sep 1.

Supplemental Content

Loading ...
Support Center